m+Medelevator.RU
← Поиск публикаций
Current oncology (Toronto, Ont.) · 2021

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.

Conference ProceedingsПоддержка исследования: вне правительства СШАConsensus StatementНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Gotfrit Joanna, Goodwin Rachel, Asmis Timothy, Hyde Angela J, Alcindor Thierry, Aubin Francine, Berry Scott, Bossé Dominick, Brown Colin, Burkes Ronald, Burnell Margot, Colwell Bruce, Corbett Jessica, Craswell Jeff, Daaboul Nathalie, Doherty Mark, Fleming D A Barry, Galvis Luisa, Goel Rakesh, Harb Mohammed, Jeyakumar Alwin, Jonker Derek, Kennedy Erin, Lock Michael, Mahmud Aamer, McCrea Patrick H, Nair Vimoj, Nassabein Rami, Nessim Carolyn, Ramjeesingh Ravi, Raza Muhammad, Saliba Wissam, Samimi Satareh, Singh Simron, Snow Stephanie, Tehfé Mustapha, Thirlwell Michael, Valdes Mario, Welch Stephen, Vickers Michael

Аннотация

The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 was held in Morell, Prince Edward Island, 19-21 September 2019. Experts in medical oncology, radiation oncology, and surgical oncology who are involved in the management of patients with gastrointestinal malignancies participated in presentations and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses multiple topics in the management of anal, colorectal, biliary tract, and gastric cancers, including: radiotherapy and systemic therapy for localized and advanced anal cancer; watch and wait strategy for the management of rectal cancer; role of testing for dihydropyrimidine dehydrogenase (DPD) deficiency prior to commencement of fluoropyrimidine therapy; radiotherapy and systemic therapy in the adjuvant and unresectable settings for biliary tract cancer; and radiotherapy and systemic therapy in the perioperative setting for early-stage gastric cancer.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты